Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.

Somatic mutations of DNMT3A gene have recently been reported in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). We examined the entire coding sequences of DNMT3A gene by high-resolution melting analysis and sequencing in Chinese patients with myeloid malignancies. R882 mutations wer...

Full description

Bibliographic Details
Main Authors: Jiang Lin, Dong-ming Yao, Jun Qian, Qin Chen, Wei Qian, Yun Li, Jing Yang, Cui-zhu Wang, Hai-yan Chai, Zhen Qian, Gao-fei Xiao, Wen-rong Xu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3204995?pdf=render
_version_ 1811195579341996032
author Jiang Lin
Dong-ming Yao
Jun Qian
Qin Chen
Wei Qian
Yun Li
Jing Yang
Cui-zhu Wang
Hai-yan Chai
Zhen Qian
Gao-fei Xiao
Wen-rong Xu
author_facet Jiang Lin
Dong-ming Yao
Jun Qian
Qin Chen
Wei Qian
Yun Li
Jing Yang
Cui-zhu Wang
Hai-yan Chai
Zhen Qian
Gao-fei Xiao
Wen-rong Xu
author_sort Jiang Lin
collection DOAJ
description Somatic mutations of DNMT3A gene have recently been reported in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). We examined the entire coding sequences of DNMT3A gene by high-resolution melting analysis and sequencing in Chinese patients with myeloid malignancies. R882 mutations were found in 12/182 AML and in 4/51 MDS, but not in either 79 chronic myeloid leukemia (CML), or 57 myeloproliferative neoplasms (MPNs), or 4 chronic monomyelocytic leukemia. No other DNMT3A mutations were detected in all patients. R882 mutations were associated with old age and more frequently present in monoblastic leukemia (M4 and M5, 7/52) compared to other subtypes (5/130). Furthermore, 14/16 (86.6%) R882 mutations were observed in patients with normal karyotypes. The overall survival of mutated MDS patients was shorter than those without mutation (median 9 and 25 months, respectively). We conclude that DNMT3A R882 mutations are recurrent molecular aberrations in AML and MDS, and may be an adverse prognostic event in MDS.
first_indexed 2024-04-12T00:45:33Z
format Article
id doaj.art-f12f9a8a52b34cc48b675434abdd9d9c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T00:45:33Z
publishDate 2011-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-f12f9a8a52b34cc48b675434abdd9d9c2022-12-22T03:54:53ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-01610e2690610.1371/journal.pone.0026906Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.Jiang LinDong-ming YaoJun QianQin ChenWei QianYun LiJing YangCui-zhu WangHai-yan ChaiZhen QianGao-fei XiaoWen-rong XuSomatic mutations of DNMT3A gene have recently been reported in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). We examined the entire coding sequences of DNMT3A gene by high-resolution melting analysis and sequencing in Chinese patients with myeloid malignancies. R882 mutations were found in 12/182 AML and in 4/51 MDS, but not in either 79 chronic myeloid leukemia (CML), or 57 myeloproliferative neoplasms (MPNs), or 4 chronic monomyelocytic leukemia. No other DNMT3A mutations were detected in all patients. R882 mutations were associated with old age and more frequently present in monoblastic leukemia (M4 and M5, 7/52) compared to other subtypes (5/130). Furthermore, 14/16 (86.6%) R882 mutations were observed in patients with normal karyotypes. The overall survival of mutated MDS patients was shorter than those without mutation (median 9 and 25 months, respectively). We conclude that DNMT3A R882 mutations are recurrent molecular aberrations in AML and MDS, and may be an adverse prognostic event in MDS.http://europepmc.org/articles/PMC3204995?pdf=render
spellingShingle Jiang Lin
Dong-ming Yao
Jun Qian
Qin Chen
Wei Qian
Yun Li
Jing Yang
Cui-zhu Wang
Hai-yan Chai
Zhen Qian
Gao-fei Xiao
Wen-rong Xu
Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
PLoS ONE
title Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
title_full Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
title_fullStr Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
title_full_unstemmed Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
title_short Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
title_sort recurrent dnmt3a r882 mutations in chinese patients with acute myeloid leukemia and myelodysplastic syndrome
url http://europepmc.org/articles/PMC3204995?pdf=render
work_keys_str_mv AT jianglin recurrentdnmt3ar882mutationsinchinesepatientswithacutemyeloidleukemiaandmyelodysplasticsyndrome
AT dongmingyao recurrentdnmt3ar882mutationsinchinesepatientswithacutemyeloidleukemiaandmyelodysplasticsyndrome
AT junqian recurrentdnmt3ar882mutationsinchinesepatientswithacutemyeloidleukemiaandmyelodysplasticsyndrome
AT qinchen recurrentdnmt3ar882mutationsinchinesepatientswithacutemyeloidleukemiaandmyelodysplasticsyndrome
AT weiqian recurrentdnmt3ar882mutationsinchinesepatientswithacutemyeloidleukemiaandmyelodysplasticsyndrome
AT yunli recurrentdnmt3ar882mutationsinchinesepatientswithacutemyeloidleukemiaandmyelodysplasticsyndrome
AT jingyang recurrentdnmt3ar882mutationsinchinesepatientswithacutemyeloidleukemiaandmyelodysplasticsyndrome
AT cuizhuwang recurrentdnmt3ar882mutationsinchinesepatientswithacutemyeloidleukemiaandmyelodysplasticsyndrome
AT haiyanchai recurrentdnmt3ar882mutationsinchinesepatientswithacutemyeloidleukemiaandmyelodysplasticsyndrome
AT zhenqian recurrentdnmt3ar882mutationsinchinesepatientswithacutemyeloidleukemiaandmyelodysplasticsyndrome
AT gaofeixiao recurrentdnmt3ar882mutationsinchinesepatientswithacutemyeloidleukemiaandmyelodysplasticsyndrome
AT wenrongxu recurrentdnmt3ar882mutationsinchinesepatientswithacutemyeloidleukemiaandmyelodysplasticsyndrome